Agile Therapeutics Inc. (AGRX)
NASDAQ: AGRX
· Real-Time Price · USD
1.51
0.05 (3.42%)
At close: Aug 22, 2024, 9:58 PM
Agile Therapeutics Revenue
Agile Therapeutics reported an annual revenue of $19.59M, reflecting a 80.02% growth. For the quarter ending June 30, 2024, Agile Therapeutics generated $5.58M in revenue.
Revenue (ttm)
19.59M
Revenue Growth
80.02%
Price / Sales Ratio
0.21
Revenue / Employee
1.03M
Employees
19
Market Cap
10.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 19.59M | +80.02% |
| Dec 31, 2022 | 10.88M | +165.40% |
| Dec 31, 2021 | 4.1M | +447.53% |
| Dec 31, 2020 | 749K | +Infinity% |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |